Identifying individuals who are at increased risk of adverse drug reactions with irinotecan and who should be considered for decreased dosing of the drug.
See UGT1A1 Test-Ordering Algorithm in Special Instructions.
Polymerase Chain Reaction (PCR) with Fragment Analysis by Capillary Gel Electrophoresis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
UGT1A1 TA Repeat Genotype
Uracil Glucuronyl transferase
Uridine Diphosphate Glucosyltransferase 1